Skip to content

Cdkn2a Cancer Predisposition Cn381201

Published: July 22, 2026Updated: August 27, 2026

A genetic predisposition increasing risk for certain cancers, particularly melanoma and pancreatic cancer. Family members may benefit from genetic testing and enhanced screening. Early detection improves management outcomes.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
C96.9
ICD-11
2A00.0
Body system
oncologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Early-onset jaundice

Family history of pancreatic cancer

(dermatologic)

Generalized symptoms

(oncologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Atypical nevi

(dermatologic)

Cutaneous melanoma

(dermatologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Dietary counseling and physical activity plan

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Enhanced cancer surveillance program

Regular screening with imaging studies, endoscopic examinations, and tumor markers appropriate to the specific cancer risks associated with CDKN2A mutations.

monitoring
3

Prophylactic surgical interventions

Consideration of risk-reducing surgeries such as mastectomy or pancreatectomy in high-risk individuals after thorough genetic counseling and multidisciplinary evaluation.

surgical

Additional treatment options

Cancer prevention lifestyle modifications

Smoking cessation, alcohol moderation, sun protection, and maintenance of healthy weight to reduce modifiable cancer risk factors.

lifestyle

Psychological support and counseling

Mental health support to address anxiety related to cancer predisposition, decision-making for prophylactic options, and coping with ongoing surveillance.

psychological

Chemoprevention considerations

Discussion of pharmacological prevention options such as NSAIDs for pancreatic cancer risk reduction in high-risk individuals.

medication

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Cdkn2a Cancer Predisposition Cn381201?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Cdkn2a Cancer Predisposition Cn381201. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy